WILMINGTON, Delaware, June 3 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * Camizestrant combination delayed time to first progression by 55% and to second progression by 37% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 trial Switching to camizestrant led to a 99% median reduction in total ctDNA vs. a 64% increase for patients who remained on standard of care 51% of patients receiving the camizestr more PR

DAVIS, California, June 2 -- The University of California Davis posted the following news: * * * Celebrated Faculty To Speak at Undergraduate Commencements * The faculty members selected to speak at the baccalaureate commencements this June have made important contributions to undergraduate teaching and learning over a total of about 120 years on campus. Collectively, their recognitions include everything from on-campus honors to a U.S. presidential award. In chronological order of the cer more PR

STANFORD, California, June 2 -- Stanford University School of Medicine posted the following news: * * * Two drugs synergize, may help cystic fibrosis, Stanford Medicine-led study shows * Two existing types of drugs synergize to improve the clearing of mucus from the lungs of animals with cystic fibrosis, a Stanford Medicine research team has found. The findings appear in the June 2026 issue of the Journal of Clinical Investigation. If replicated in humans, the discovery may provide a way t more PR